Biotech · Public company · Irvine, CA, US
Tarsus Pharmaceuticals, Inc.
Ticker TARS · SEC CIK 0001819790
Track this companyFree. Adds Tarsus Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials113 recruiting or active
Pipeline programs20From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline20
- TP-03Phase 3 · BlepharitisClinicalTrials.gov · fetched Nov 12, 2026
- TP-03 VehiclePhase 3 · BlepharitisClinicalTrials.gov · fetched Nov 12, 2026
- TP-03, 0.25%Phase 3 · BlepharitisClinicalTrials.gov · fetched Nov 12, 2026
- High Dose TP-05Phase 2 · Healthy VolunteerClinicalTrials.gov · fetched Nov 12, 2026
- lotilanerPhase 2 · Ocular RosaceaClinicalTrials.gov · fetched Nov 12, 2026
- Low Dose TP-05Phase 2 · Healthy VolunteerClinicalTrials.gov · fetched Nov 12, 2026
- TP-03Phase 2 · Meibomian Gland DysfunctionClinicalTrials.gov · fetched Nov 12, 2026
- TP-03 VehiclePhase 2 · Meibomian Gland DysfunctionClinicalTrials.gov · fetched Nov 12, 2026
- TP-05 (lotilaner) High DosePhase 2 · Lyme DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- TP-05 (lotilaner) Low DosePhase 2 · Lyme DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- TP-06Phase 2 · Persistent Corneal Epithelial DefectClinicalTrials.gov · fetched Nov 12, 2026
- VehiclePhase 2 · Ocular RosaceaClinicalTrials.gov · fetched Nov 12, 2026
- Vehicle of TP-03Phase 2 · Meibomian Gland DysfunctionClinicalTrials.gov · fetched Nov 12, 2026
- Vehicle of TP-06Phase 2 · Persistent Corneal Epithelial DefectClinicalTrials.gov · fetched Nov 12, 2026
- TP-05 (lotilaner oral capsules)Phase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- TP-05 (lotilaner oral), fasted groupPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- TP-05 (lotilaner oral), high-fat groupPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- TP-05 (lotilaner oral), low-fat groupPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- Lotilaner ophthalmic solution, 0.25%Demodex BlepharitisClinicalTrials.gov · fetched Nov 12, 2026
- Vehicle controlDemodex BlepharitisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials11
- A Study to Evaluate the Efficacy and Safety of TP-06 for PCEDPHASE2 · RECRUITING · started Apr 20, 2026ClinicalTrials.gov NCT07886268 · fetched Nov 12, 2026
- A Study to Evaluate Safety and Efficacy of TP-05 in Healthy Participants With Tick ExposurePHASE2 · ACTIVE_NOT_RECRUITING · started Mar 9, 2026ClinicalTrials.gov NCT07562087 · fetched Nov 12, 2026
- Study of Lotilaner Ophthalmic Gel in Patients With Ocular Rosacea (KORE)PHASE2 · ENROLLING_BY_INVITATION · started Dec 5, 2025ClinicalTrials.gov NCT07443202 · fetched Nov 12, 2026
- Impact of XDEMVY® on Demodex Blepharitis in Soft Contact Lens WearersPHASE4 · COMPLETED · started Dec 27, 2023ClinicalTrials.gov NCT06182358 · fetched Nov 12, 2026
- Effect of an Exploratory Vehicle on Meibomian Gland Dysfunction in Patients With DemodexPHASE2 · UNKNOWN · started Aug 1, 2023ClinicalTrials.gov NCT06054217 · fetched Nov 12, 2026
- Study to Evaluate the Food Effect of TP-05 in Healthy ParticipantsPHASE1 · COMPLETED · started Jan 19, 2023ClinicalTrials.gov NCT05720364 · fetched Nov 12, 2026
- A Human Tick Kill Study to Investigate the Safety, Tolerability, and Whole Blood Concentration of TP-05PHASE2 · COMPLETED · started Dec 12, 2022ClinicalTrials.gov NCT05387083 · fetched Nov 12, 2026
- Pilot Study Comparing the Safety and Efficacy of Two Dosing Regimens of TP-03 for the Treatment of MGDPHASE2 · COMPLETED · started Aug 3, 2022ClinicalTrials.gov NCT05454956 · fetched Nov 12, 2026
- A Pharmacokinetic Study of TP-05 in Healthy SubjectsPHASE1 · COMPLETED · started May 6, 2021ClinicalTrials.gov NCT05138796 · fetched Nov 12, 2026
- Trial to Evaluate the Safety and Efficacy of TP-03 for the Treatment of Demodex BlepharitisPHASE3 · COMPLETED · started Apr 29, 2021ClinicalTrials.gov NCT04784091 · fetched Nov 12, 2026
- Safety and Efficacy of TP-03 for the Treatment of Demodex BlepharitisPHASE2_PHASE3 · COMPLETED · started Sep 9, 2020ClinicalTrials.gov NCT04475432 · fetched Nov 12, 2026
SEC filings12
- 10-Q · 10-QSEC EDGAR · filed Nov 3, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Nov 3, 2026 · fetched Nov 12, 2026
- 8-K/A · 8-K/ASEC EDGAR · filed Oct 13, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Sep 10, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 6, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 6, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 6, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 6, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jul 13, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jul 8, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 29, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 6, 2026 · fetched Nov 12, 2026